Press release
Hospital Infection Therapeutics Market: Rising Demand and Value Growth Trend Towards US$ 14.4 Bn by 2031 - TMR Insights
Hospital Infection Therapeutics
The hospital infection therapeutics market was valued at US$ 11.3 billion in 2022 and is projected to grow at a CAGR of 2.6% from 2023 to 2031. By the end of 2031, the market is expected to reach US$ 14.4 billion. This steady growth is driven by rising hospital admissions, advancements in antimicrobial treatments, and the adoption of stringent infection control measures worldwide.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1280
Analyst Viewpoint
Market analysts anticipate moderate but sustained growth in the hospital infection therapeutics market. The increasing prevalence of antibiotic-resistant infections, coupled with government initiatives for better infection control, is expected to fuel market expansion. However, challenges such as antibiotic overuse, regulatory hurdles, and the high cost of novel therapeutics may hinder growth.
Key Market Drivers
Rising Incidence of Healthcare-Associated Infections (HAIs) - The growing number of hospital-acquired infections drives the need for advanced therapeutics.
Antimicrobial Resistance (AMR) Concerns - Increased resistance to existing antibiotics creates demand for novel treatment solutions.
Advancements in Drug Development - Continuous research and innovation in antimicrobial therapies enhance treatment efficacy.
Government and Regulatory Support - Policies promoting antibiotic stewardship programs and infection control boost market demand.
Expanding Healthcare Infrastructure - Growth in hospital and clinical facilities, particularly in developing regions, increases the need for infection therapeutics.
Recent Developments
2021 - Pfizer introduced an advanced antimicrobial therapy targeting multidrug-resistant pathogens in hospital settings.
2022 - Merck & Co. launched a new combination antibiotic for treating severe nosocomial infections.
2023 - GlaxoSmithKline (GSK) announced promising clinical trial results for a next-generation antimicrobial agent.
2024 - Johnson & Johnson expanded its hospital infection therapeutics portfolio with a novel antifungal treatment for immunocompromised patients.
Key Players
Merck & Co., Inc.
Pfizer, Inc.
GlaxoSmithKline plc
AstraZeneca
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd.
Bayer AG
Allergan plc
Sanofi S.A.
Gilead Sciences, Inc.
Basilea Pharmaceutica Ltd.
Bristol-Myers Squibb Company
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1280
Market Trends and Opportunities
The hospital infection therapeutics market is witnessing increased research in next-generation antibiotics, monoclonal antibodies, and antimicrobial peptides. The adoption of AI-driven drug discovery is also accelerating the development of effective treatments. Additionally, expanding hospital infrastructure in emerging economies presents significant growth opportunities for market players.
Market Segmentation
By Infection Type
Bacterial Infections
Viral Infections
Fungal Infections
Parasitic Infections
By Drug Class
Antibiotics
Antivirals
Antifungals
Antiparasitics
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Future Outlook
The hospital infection therapeutics market is expected to see continued growth, supported by innovations in antimicrobial treatments and increasing government initiatives to combat hospital-acquired infections. The shift towards personalized medicine and rapid diagnostics will further shape the market landscape in the coming years.
Regional Analysis
North America - Leading market share due to high healthcare spending and robust infection control measures.
Europe - Significant growth driven by regulatory frameworks and increasing awareness of antimicrobial resistance.
Asia-Pacific - Expected to witness the fastest growth due to rising healthcare infrastructure and increasing infection rates.
Latin America & Middle East & Africa - Emerging markets with growing healthcare investments and unmet medical needs.
Explore Latest Research Reports by Transparency Market Research:
Healthcare Biometrics Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-biometrics-market-to-surpass-us-7408-billion-by-2035-driven-by-advancements-in-security-digital-health-solutions-tmr-insights
Healthcare Contract Research Outsourcing Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-contract-research-outsourcing-market-to-surpass-us-6309-billion-by-2035-driven-by-increasing-demand-for-cost-effective-drug-development
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hospital Infection Therapeutics Market: Rising Demand and Value Growth Trend Towards US$ 14.4 Bn by 2031 - TMR Insights here
News-ID: 3947129 • Views: …
More Releases from Transparency Market Research
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / …
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,…
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac …
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,…
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% …
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036.
This growth trajectory highlights the increasing reliance on…
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US …
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation by…
More Releases for Infection
Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Infection Prevention Market?
In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market…
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market?
The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization.
The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven…
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The yeast infection…
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications.
The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few…
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing…
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026.
The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,…
